FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Track all the latest updates and news of GreenSignal Bio Pharma IPO.
June 8, 2024 3:30:00 AM
Get full access to SWOT Analysis of stock with Moneycontrol Pro.
Published by : moneycontrol.comJune 7, 2024 2:30:00 PM
Biopharma IPOs jumped after the J.P. Morgan Healthcare Conference in January, with a $380 million debut from CG Oncology and Kyverna Therapeutics� $319 million offering. However, that uptick was ...
Published by : FierceBiotechJune 10, 2024 3:31:00 AM
These are the upcoming IPOs (initial public offerings) for the week of June 10 to June 14, based on the TipRanks IPO Calendar. An IPO refers to the public market debut of a private company.
Published by : MSNJune 25, 2024 3:30:00 AM
It expects shares to go on sale the week of June 24. Proceeds from the IPO will be used for clinical trials and product development, research and development, clinical manufacturing and working ...
Published by : The Business JournalsJune 28, 2024 8:31:00 PM
Shares of Alumis Inc. sank 20% in the clinical stage biopharmaceutical company�s public debut, after it raised $250 million in a downsized initial public offering with a concurrent private placement.
Published by : Bloomberg L.P.June 17, 2024 3:30:00 AM
The biopharma IPO market continues to heat up. In the past few weeks, one company set terms for an upcoming initial public offering and a second filed preliminary plans. And yet another fledgling ...
Published by : Institutional InvestorJune 12, 2024 7:17:00 PM
CrowdStrike marks the 5-year anniversay of its IPO with significant milestones and momentum and ... [+] being added to the S&P 500. As CrowdStrike marks the fifth anniversary of its IPO ...
Published by : ForbesJune 10, 2024 10:20:00 PM
Media network Newsmax plans to publicly list its shares later this year and is looking to raise capital beforehand via a private placement. Boca Raton, Fla.-based Newsmax said Monday in an ...
Published by : Wall Street JournalJune 25, 2024 3:30:00 AM
An Australian natural gas company is planning to list its shares in the United States this week in a rare non-biopharma IPO. And one hedge fund giant is poised to be a major beneficiary of the ...
Published by : Institutional InvestorJune 28, 2024 7:28:00 PM
Shares of biopharmaceutical firm Alumis opened nearly 16% below their initial public offering (IPO) price in their debut on the Nasdaq on Friday.
Published by : ReutersGreenSignal Bio Pharma Ltd IPO to open on Nov 09, 2016 and close for subscription on Nov 22, 2016. The price band for the issue has been fixed at Rs 68 at lower level and Rs 76 at upper level. The equity shares of the company to be list at BSE and NSE.
GreenSignal Bio Pharma Ltd is entering in the capital markets with an initial public offering, IPO of 14,579,560 Equity Shares of Rs 10. The price band for the issue has been fixed at Rs 68 at lower level and Rs 76 at upper level.
GreenSignal Bio Pharma is Chennai based pharmaceutical company engaged in the development, manufacture and sale of the BCG vaccine. source chittorgarh.com, India's No. 1 IPO Investment Portal. GreenSignal is an Indian vaccine manufacturing company with global operations. The products company manufacture includes a BCG vaccine and BCG-ONCO, an immunotherapy drug. The immunotherapy drug is used in the treatment of urinary bladder cancer.
The issue opens on Nov 09, 2016 and closes for subscription on Nov 22, 2016. The equity shares of the issue are proposed to be list on the Bombay Stock Exchange (BSE) and National Stock Exchange (NSE).
The GreenSignal Bio Pharma IPO is proposed to open on November 9, 2016. The IPO application ends on November 22, 2016.
Retail investors can apply in the retail or non-institutional investor category from November 9, 2016 to November 22, 2016. The GreenSignal Bio Pharma IPO can be applied online through Net Bank (ASBA method) or the stock broker (UPI method).
The GreenSignal Bio Pharma IPO will open for subscription on November 9, 2016. The public issue will close on November 22, 2016.
Useful Articles
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|